182 filings
Page 4 of 10
DEFA14A
fzr nm86e93
26 Apr 22
Additional proxy soliciting materials
7:04am
S-8
8r4ncpg3xcafla5mpspd
2 Mar 22
Registration of securities for employees
7:53am
8-K
f752qw4m
2 Mar 22
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021
7:02am
8-K
t5j91zgm 5x
15 Dec 21
Surface Oncology Appoints Denice Torres as Chair of the Board of Directors
7:00am
8-K
7guog7kj4zn
6 Dec 21
Surface Oncology Presents Promising Clinical Data on SRF617 at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021
9:27am
8-K
5ps6umdrb073rhw
4 Nov 21
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2021
7:01am
8-K
0tqc93ib4 tb83
4 Oct 21
Entry into a Material Definitive Agreement
7:05am
EFFECT
7nfjuznvn7j8qo c3e
16 Aug 21
Notice of effectiveness
12:15am
CORRESP
51kk24b6
11 Aug 21
Correspondence with SEC
12:00am
UPLOAD
vx9m18 ku0kh
11 Aug 21
Letter from SEC
12:00am
8-K
9nr l5pi0hn
5 Aug 21
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2021
7:02am
8-K
zqt5qcuz8z
8 Jul 21
Surface Oncology Appoints Denice Torres to Board of Directors
7:05am
8-K
83307trbjkw3t
10 Jun 21
Submission of Matters to a Vote of Security Holders
8:00am
8-K
kfcy8s
4 Jun 21
SRF388, a First-in-Class IL-27 Antibody, Demonstrates Monotherapy Activity in Data Presented at American Society of Clinical Oncology Annual Meeting
7:15am